N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer

The Tumorigenic Effect of lncRNA AFAP1‐AS1 is Mediated by Translated Peptide ATMLP Under the Control of m6A Methylation

(2023) Hailong Pei et al.   Advanced Science

A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer

(2023) Jianming Lu et al.   Translational Oncology

A novel defined risk signature based on pyroptosis-related genes can predict the prognosis of prostate cancer

(2022) Ding Hu et al.   BMC Medical Genomics

Cancer statistics, 2022

(2022) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Hallmarks of Cancer: New Dimensions

(2022) Douglas Hanahan   Cancer Discovery

Knockdown of long non-coding RNA SNHG8 suppresses the progression of esophageal cancer by regulating miR-1270/BACH1 axis

(2022) Yonghong Wu et al.   Bioengineered

Comprehensive Evaluation of Machine Learning Models and Gene Expression Signatures for Prostate Cancer Prognosis Using Large Population Cohorts

(2022) Ruidong Li et al.   CANCER RESEARCH

Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis

(2022) Chenmeng Li et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

m6A-immune-related lncRNA prognostic signature for predicting immune landscape and prognosis of bladder cancer

(2022) Zi-Hao Feng et al.   Journal of Translational Medicine

A single N6-methyladenosine site regulates lncRNA HOTAIR function in breast cancer cells

(2022) Allison M. Porman et al.   PLOS BIOLOGY

Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1‐targeting miRNA‐92a‐1‐5p

(2021) Lijuan Yu et al.   Journal of Extracellular Vesicles

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Epigenetic modulation reveals differentiation state specificity of oncogene addiction

(2021) Mehwish Khaliq et al.   Nature Communications

Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer

(2021) Chuanfan Zhong et al.   Cell Death & Disease

m 6 A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2 ‐mediated IGF1R mRNA stabilization

(2021) Chuandong Lang et al.   Clinical and Translational Medicine

Hypoxia‐inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy

(2021) Kuo‐Hao Ho et al.   CANCER SCIENCE

MIR210HG promotes cell proliferation and invasion by regulating miR-503-5p/TRAF4 axis in cervical cancer

(2020) Ai-Hong Wang et al.   Aging-US

N6-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription

(2020) Jun Liu et al.   SCIENCE

Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications

(2020) Juan Carrillo-Reixach et al.   JOURNAL OF HEPATOLOGY

Dynamic landscape and evolution of m6A methylation in human

(2020) Hui Zhang et al.   NUCLEIC ACIDS RESEARCH

Novel insights into the interplay between m6A modification and noncoding RNAs in cancer

(2020) You-Cai Yi et al.   Molecular Cancer

The ERG-Regulated LINC00920 Promotes Prostate Cancer Cell Survival via the 14-3-3ε–FOXO Pathway

(2020) Arlou Kristina Angeles et al.   MOLECULAR CANCER RESEARCH

Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in osteosarcoma chemo-resistance

(2019) Kun-Peng Zhu et al.   MOLECULAR THERAPY

MIR210HG predicts poor prognosis and functions as an oncogenic lncRNA in hepatocellular carcinoma

(2019) Yan Wang et al.   BIOMEDICINE & PHARMACOTHERAPY

IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader

(2019) Xiaoge Hu et al.   CELL DEATH AND DIFFERENTIATION

METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m 6 A Modification

(2018) Hengyou Weng et al.   Cell Stem Cell

RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2

(2018) Mengnuo Chen et al.   HEPATOLOGY

EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

(2017) Nicolas Mottet et al.   EUROPEAN UROLOGY

Nuclear m 6 A Reader YTHDC1 Regulates mRNA Splicing

(2016) Wen Xiao et al.   MOLECULAR CELL

N6-methyladenosine Modulates Messenger RNA Translation Efficiency

(2015) Xiao Wang et al.   CELL

Integrative analysis of 111 reference human epigenomes

(2015) Anshul Kundaje et al.   NATURE

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

The Molecular Signatures Database Hallmark Gene Set Collection

(2015) Arthur Liberzon et al.   Cell Systems

GSVA: gene set variation analysis for microarray and RNA-Seq data

(2013) Sonja Hänzelmann et al.   BMC BIOINFORMATICS

N6-methyladenosine-dependent regulation of messenger RNA stability

(2013) Xiao Wang et al.   NATURE

Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq

(2012) Dan Dominissini et al.   NATURE

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

(2012) Guangchuang Yu et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Imaging individual mRNA molecules using multiple singly labeled probes

(2008) Arjun Raj et al.   NATURE METHODS